Gene therapy revolutionizes retinal disease treatment, offering long-lasting solutions and reducing the need for frequent injections in patients with nAMD.
Lejla Vajzovic, MD
Advertisement
Professor of ophthalmology and director of CME at Duke University School of Medicine, Durham, NC
Articles by Lejla Vajzovic, MD
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on Modern Retina
1
From AI to injury patterns: Insights from emerging ophthalmic research
2
FLORetina 2025: Reframing retinal disease through the lens of choroidal health
3
Q&A: Veeral Sheth, MD, MBA, on personalized, imaging-centered geographic atrophy care
4
FLORetina 2025: Mary Elizabeth Hartnett on ROP research and risk management
5
